CurtissWright Corp Positioned for Growth Amid Geopolitical Uncertainty Says Meridian Funds Alibaba Unveils NextGeneration Zhenwu AI Chip and New Large Language Model Gold Prices Hold Steady as Investors Await USIran Peace Talks Outcome CBS Ends The Late Show Era Paul McCartneys Finale Highlights Financial Decision Behind Cancellation US Payrolls Surge Past Forecasts But Report Reveals Underlying Economic Caution Mercury Achieves 52 Billion Valuation Amid Fintech Sector Resurgence HAE Q1 2026 Earnings EPS Slightly Beats Estimates Stock Reacts Positively ACR Q1 2026 Earnings EPS Misses Estimates Amid Challenging Commercial Real Estate Environment KRP Q1 2026 Earnings Steep Earnings Miss Amid Challenging Environment Enhabit Inc EHAB Q4 2025 Earnings EPS Misses Estimates by a Narrow Margin Stock Edges Higher NEON Q1 2026 Earnings EPS Misses Estimates Amid Elevated Operating Costs RGTI Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Quantum Computing Development LiveRamp Holdings RAMP Slight Dip Amid Consolidation Near Resistance Kayne Anderson Energy Infrastructure Fund KYN Edges Lower as It Tests Support Within Tight Trading Range Afya Limited AFYA Edges Higher as Stock Holds Above Key Support Level P3 Health Partners Warrant PIIIW Nears Penny Territory Down 1093 at 002 Suzano SUZ Edges Lower Amid Mixed Market Signals Key Support in Focus QXO Launches Hostile Takeover Bid for Beacon After Repeated Rejections RPM Q1 2026 Earnings Strong EPS Beat Driven by Margin Expansion and Operational Efficiency FS Bancorp Inc FSBW Gains 157 as Stock Approaches Key Resistance Level C4 Therapeutics Q1 2026 Earnings EPS Surprises to the Upside as Biotech Focuses on Pipeline Execution PCB Bancorp PCB Q1 2026 Earnings EPS Surprises to the Upside Amid Steady Core Operations Central Garden Pet Company CENTA Q1 2026 Earnings Earnings Beat Driven by Operational Discipline Amid Mixed TopLine Signals CMSD Q1 2026 Earnings Utility Core Earnings Beat Estimate Shares Edge Higher ALBT Q1 2026 Earnings Narrowed Losses Maintain Focus on Cell Therapy Pipeline RXRX Q1 2026 Earnings EPS Beat Despite No Revenue Stock Slips 32 Scholastic Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline